More Information: Minus iconIcon indicating subtraction, or that the element can be closed. Plus IconIcon indicating addition, or that the element can be opened. Arrow (down) icon.An arrow icon, usually indicating that the containing element can be opened and closed.

SK-N-MC-IXC: Human Neuroblastoma Cell Line



SK-N-MC-IXC is a twice-sub-cloned cell line derived from the SK-N-MC cell line. These cells share many characteristics with the parental cell line. Unlike the SK-N-MC cell line, however, these cells contain a variable number of double-minute chromosomes. At the time of establishment, double-minute chromosomes were present in almost 90 percent of the cells examined and varied in number and size. Like the parental cell line, the SK-N-MC-IXC cells have little or no dopamine-b-hydroxylase activity. They do, however, have significantly increased choline acetyltransferase activity compared to the parental SK-N-MC cell line.


This cell line was derived from the SK-N-MC-IX subclone of the parental SK-N-MC cell line. The parental cell line was established in 1971 from a metastatic site (supra-orbital region) in a 14-year-old Caucasian female with an Askin’s tumor.


  • June L. Biedler, PhD, former Chairman, Cell Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering
  • Barbara A. Spengler, formerly at Sloan Kettering Institute, Memorial Sloan Kettering

Key References

  • Biedler JL et al. (1973) Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Research 33: 2643-2652 (PubMed ID: 4748425)
  • Biedler JL et al. (1978) Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Research 38: 3751-3757 (PubMed ID: 29704)

Licensing Information

This cell line may be licensed nonexclusively for research or commercial purposes.

Contact Information

  • For licensing requests: Alexandra Buga, MBA, Business Development Analyst, Office of Technology Development, MSK, 646-888-1078,
  • For non-licensing requests from academic-research institutions: Frances Weis-Garcia, PhD, Associate Laboratory Member/Head, Antibody & Bioresource Core Facility, MSK, 646-888-2354,

Stage of Development

Ready to use